Northern Trust
CLPT icon

Northern Trust’s ClearPoint Neuro CLPT Stock Holding History

Northern Trust’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12M Buy
230,986
+21,560
+10% +$269K ﹤0.01% 2727
2026
Q1 		$1.91M Buy
209,426
+16,058
+8% +$203K ﹤0.01% 3001
2025
Q4 		$2.65M Sell
193,368
-12,468
-6% -$231K ﹤0.01% 2833
2025
Q3 		$4.49M Buy
205,836
+1,086
+0.5% +$12.8K ﹤0.01% 2563
2025
Q2 		$2.44M Buy
204,750
+148,472
+264% +$1.87M ﹤0.01% 2868
2025
Q1 		$669K Buy
56,278
+2,713
+5% +$42.2K ﹤0.01% 3452
2024
Q4 		$824K Sell
53,565
-1,394
-3% -$18.1K ﹤0.01% 3470
2024
Q3 		$616K Sell
54,959
-127,663
-70% -$1.22M ﹤0.01% 3521
2024
Q2 		$984K Sell
182,622
-15,197
-8% -$87.9K ﹤0.01% 3256
2024
Q1 		$1.35M Sell
197,819
-66
-0% -$461 ﹤0.01% 3174
2023
Q4 		$1.34M Buy
197,885
+8,133
+4% +$46K ﹤0.01% 3194
2023
Q3 		$951K Sell
189,752
-4,349
-2% -$25.9K ﹤0.01% 3312
2023
Q2 		$1.41M Buy
194,101
+154,952
+396% +$1.32M ﹤0.01% 3212
2023
Q1 		$330K Buy
39,149
+4,042
+12% +$35.4K ﹤0.01% 3623
2022
Q4 		$297K Hold
35,107
– – ﹤0.01% 3685
2022
Q3 		$364K Buy
35,107
+4,106
+13% +$54.1K ﹤0.01% 3612
2022
Q2 		$404K Sell
31,001
-132,599
-81% -$1.35M ﹤0.01% 3617
2022
Q1 		$1.7M Sell
163,600
-6,543
-4% -$59.6K ﹤0.01% 3173
2021
Q4 		$1.91M Buy
170,143
+2,488
+1% +$37.2K ﹤0.01% 3238
2021
Q3 		$2.98M Sell
167,655
-8,771
-5% -$164K ﹤0.01% 3057
2021
Q2 		$3.37M Buy
176,426
+148,904
+541% +$2.88M ﹤0.01% 3074
2021
Q1 		$582K Buy
27,522
+6,504
+31% +$139K ﹤0.01% 3766
2020
Q4 		$334K Buy
21,018
+9,852
+88% +$88.4K ﹤0.01% 3826
2020
Q3 		$61K Buy
11,166
+113
+1% +$498 ﹤0.01% 4075
2020
Q2 		$39K Hold
11,053
– – ﹤0.01% 4086
2020
Q1 		$40K Sell
11,053
-450
-4% -$2.21K ﹤0.01% 3986
2019
Q4 		$55K Buy
+11,503
New +$47.6K ﹤0.01% 4041

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Northern Trust's CLPT Position: Q2 2026 in Review

Northern Trust increased its ClearPoint Neuro (CLPT) stake by 10% in Q2 2026, buying an estimated $269K and bringing the position to 230,986 shares worth $4.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2727.

Northern Trust first reported a position in CLPT in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.49M in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Northern Trust held 230,986 shares of ClearPoint Neuro worth $4.12M as of Q2 2026.
  • Northern Trust bought 21,560 ClearPoint Neuro shares in Q2 2026, an estimated $269K.
  • ClearPoint Neuro made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2727 holding.
  • Northern Trust first reported a position in ClearPoint Neuro in Q4 2019 and has held it in 27 quarters since.
  • Northern Trust's ClearPoint Neuro position peaked at $4.49M in Q3 2025.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.